OBJECTIVES
Slide 3 of 77
Go to slide:
1: (Untitled)
2: (Untitled)
3: OBJECTIVES
4: (Untitled)
5: (Untitled)
6: (Untitled)
7: (Untitled)
8: (Untitled)
9: 7 CATEGORIES
10: AVAILABLE ANTIBIOTICS
11: (Untitled)
12: (Untitled)
13: (Untitled)
14: (Untitled)
15: (Untitled)
16: (Untitled)
17: (Untitled)
18: (Untitled)
19: (Untitled)
20: (Untitled)
21: (Untitled)
22: ANTIBIOTICS
23: ANTIBIOTICS
24: (Untitled)
25: (Untitled)
26: (Untitled)
27: PENICILLINS
28: (Untitled)
29: (Untitled)
30: (Untitled)
31: (Untitled)
32: (Untitled)
33: (Untitled)
34: CEPHALOSPORINS
35: CEPHALOSPORINS
36: CEPHALOSPORINS
37: (Untitled)
38: (Untitled)
39: (Untitled)
40: (Untitled)
41: NOSOCOMIAL SEPTICEMIA
42: (Untitled)
43: OVERVIEW: OUTPATIENT INFECTIONS
44: LOWER RESPIRATORY INFECTIONS
45: LOWER RESPIRATORY INFECTIONS
46: RENEWED INTEREST IN NON-BETA LACTAMS
47: (Untitled)
48: STREPTOGRAMINS
49: (Untitled)
50: (Untitled)
51: (Untitled)
52: (Untitled)
53: (Untitled)
54: (Untitled)
55: (Untitled)
56: (Untitled)
57: (Untitled)
58: (Untitled)
59: (Untitled)
60: (Untitled)
61: (Untitled)
62: MACROLIDES
63: MACROLIDES
64: (Untitled)
65: (Untitled)
66: (Untitled)
67: CLARITHROMYCIN
68: (Untitled)
69: AZITHROMYCIN
70: AZITHROMYCIN
71: AZITHROMYCIN
72: (Untitled)
73: (Untitled)
74: (Untitled)
75: (Untitled)
76: (Untitled)
77: (Untitled)
